Journal article
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.
- Abstract:
-
Between 1998 and 2001, Kenya, Uganda, Tanzania, Zanzibar, Rwanda and Burundi changed antimalarial drug policy, in the face of widespread chloroquine resistance. The new first-line treatment is either sulphadoxine-pyrimethamine (SP) monotherapy, or a combination of SP with either chloroquine or amodiaquine. Two national malaria control programmes, Burundi and Zanzibar, have decided upon amodiaquine-artesunate as their first-line treatment, although SP will continue to fill this role until the ...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Tropical medicine and international health : TM and IH
- Volume:
- 8
- Issue:
- 10
- Pages:
- 860-867
- Publication date:
- 2003-10-01
- DOI:
- EISSN:
-
1365-3156
- ISSN:
-
1360-2276
- Source identifiers:
-
38750
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:38750
- UUID:
-
uuid:63e28e64-167a-4394-9711-8b32f44c3a90
- Local pid:
- pubs:38750
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2003
If you are the owner of this record, you can report an update to it here: Report update to this record